covid 19 News and Research

RSS

Researchers define key questions to help the UK government for next biosecurity threat

During the summer of 2019, a global team of experts put their heads together to define the key questions facing the UK government when it comes to biological security.

4 Feb 2021

Predicting future mamalian hosts of SARS-CoV-2

Researchers at the Beijing Computational Science Research Center and Peking University analyzed sequences of the angiotensin-converting enzyme 2 (ACE2) proteins from 16 mammals and predicted the structures of ACE2- receptor-binding domain (RBD) complexes.

4 Feb 2021

Russia's Sputnik V COVID-19 shown to have 91.6 percent efficacy

The phase 3 human trial is the last stage of clinical evaluation, showing how effective and safe a drug or vaccine is. In this case, the Gam- Sputnik V showed a consistent strong protective effect across all participant age groups.

3 Feb 2021

Hematological findings in Amazonian patients with COVID-19

To discriminate between patients with severe and non-severe COVID-19 quickly, researchers from Peru looked for prognostic signatures in the blood samples of COVID-19 patients. Virgilio E. Failoc-Rojas et al. examined laboratory results and clinical prognosis of COVID-19 patients from a hospital in the Peruvian Amazon.

3 Feb 2021

Survey finds 41% of United States residents unwilling to receive a COVID-19 vaccine

A cross-sectional online survey conducted by the scientists of Johns Hopkins Bloomberg School of Public Health, USA, has revealed that about 41% of US residents are unwilling to receive a coronavirus disease 2019 (COVID-19) vaccine due to concern over vaccine safety and efficacy. Moreover, there are sub-group variations in willingness to receive a COVID-19 vaccine

3 Feb 2021

Nasodine antiseptic nasal spray shows potential antiviral activity against SARS-CoV-2

A team of international scientists has recently investigated the efficacy of PVP-1, a complex of polyvinylpyrrolidone and iodine, in preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Using in vitro cell culture settings, the scientists observe that PVP-1 formulation used in a commercially available nasal spray (Nasodine) readily inactivates SARS-CoV-2 within a short period of time.

3 Feb 2021

Prevalence of underlying medical conditions related to severe COVID-19 is higher among cancer survivors

New study finds more than half (56.4%) of cancer survivors in the United States reported having additional underlying medical conditions associated with severe COVID-19 illness.

3 Feb 2021

Insight into role of aging in response to SARS-CoV-2 infection

Researchers at the University of California, Irvine set out to determine the differences between young people and older adults regarding their host responses against SARS-CoV-2. The team revealed that independent of disease severity, COVID-19 was linked to a significant shift in plasma inflammatory factors. The research is posted to the pre-print server medRxiv*.

3 Feb 2021

COVID-19 vaccine should be recommended to patients with Parkinson’s disease, experts say

Patients with Parkinson's disease (PD) and healthcare professionals caring for them have expressed concerns about the COVID-19 vaccine's efficacy and safety in the specific context of PD and its symptomatic treatment.

3 Feb 2021

Study reveals a deep digital health divide within the older population

The COVID-19 pandemic is a great example of the importance of access to the Internet and to digital health information.

3 Feb 2021

How well do fabric face masks protect from COVID?

In a new study, published on the pre-print server medRxiv, researchers at the University of Cambridge found that fabric face masks block 62.6 percent to 87.1 percent of fine particles, making them useful tools in the battle against the COVID-19 pandemic.

3 Feb 2021

Study gives new clues to how muscle wasting occurs on a cellular level

Muscle wasting, or the loss of muscle tissue, is a common problem for people with cancer, but the precise mechanisms have long eluded doctors and scientists. Now, a new study led by Penn State researchers gives new clues to how muscle wasting happens on a cellular level.

3 Feb 2021

Clinical trials of new treatments for COVID-19 often do not include vulnerable populations

Studies examining the effectiveness of treatments for COVID-19 often do not include the very populations hardest hit by the disease, according to a new review by University of Chicago Medicine researchers.

3 Feb 2021

Early use of therapeutic anticoagulation does not improve survival of critically ill COVID-19 patients

Although abnormal blood clotting has been identified as one of the primary causes of death from COVID-19, early treatment in an intensive care unit (ICU) with therapeutic anticoagulation (anti-clotting) for adults who are critically ill with COVID-19 does not appear to improve chances of survival, and could do more harm than good by increasing the risk for major bleeding, a multicenter research group cautions.

3 Feb 2021

covid 19 News and Research

Researchers define key questions to help the UK government for next biosecurity threat

Predicting future mamalian hosts of SARS-CoV-2

Russia's Sputnik V COVID-19 shown to have 91.6 percent efficacy

Hematological findings in Amazonian patients with COVID-19

Survey finds 41% of United States residents unwilling to receive a COVID-19 vaccine

Nasodine antiseptic nasal spray shows potential antiviral activity against SARS-CoV-2

Prevalence of underlying medical conditions related to severe COVID-19 is higher among cancer survivors

Insight into role of aging in response to SARS-CoV-2 infection

COVID-19 vaccine should be recommended to patients with Parkinson’s disease, experts say

Study reveals a deep digital health divide within the older population

How well do fabric face masks protect from COVID?

Study gives new clues to how muscle wasting occurs on a cellular level

Clinical trials of new treatments for COVID-19 often do not include vulnerable populations

Early use of therapeutic anticoagulation does not improve survival of critically ill COVID-19 patients

Latest clinical trial supports UK’s decision to delay second COVID vaccine dose

Dispelling vaccine misinformation and myths in California’s breadbasket

Viral load the main driver of SARS-CoV-2 transmission

Novel personalized screening tool to better detect suicidal youths

Could rapid result low sensitivity SARS-CoV-2 tests improve pandemic quarantine strategies?

Researchers engineer "Nanotraps" that block SARS-CoV-2 infection

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News